multiple myeloma

No retained variant associations.

1. 2026Genome-Guided Discovery and Heterologous Biosynthesis of Alkylresorcinols by Collaborating Highly Reducing and Type III Polyketide Synthases.Journal of natural products1 mentions
2. 2026Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity.Critical reviews in oncology/hematology1 mentions
3. 2026Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review.Blood and lymphatic cancer : targets and therapy1 mentions
4. 2026Mass spectrometry-based proteomics and metabolomics in multiple myeloma: a systematic review of prognostic biomarkers and minimal residual disease monitoring.Frontiers in medicine1 mentions
5. 2025Investigation and drug design for novel molecules from natural products as inhibitors for controlling multiple myeloma disease using in-silico tools.Journal of biomolecular structure & dynamics1 mentions
6. 2025Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab - case report and review of the literature.Annals of hematology1 mentions
7. 2025The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders.Experimental cell research1 mentions
8. 2025Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies.Experimental hematology1 mentions
9. 2025Plasmablastic Lymphoma-A Crosstalk Between Myeloma and Lymphoma.Clinical lymphoma, myeloma & leukemia1 mentions
10. 2025Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment.Future medicinal chemistry1 mentions
11. 2025Machine Learning for Multi-Omics Characterization of Blood Cancers: A Systematic Review.Cells1 mentions
12. 2025Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics.Communications biology1 mentions
13. 2024CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.Annals of hematology1 mentions
14. 2024Use of venetoclax in t(11;14) positive relapsed/refractory multiple myeloma: A systematic review.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners1 mentions
15. 2024Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects.Hematology (Amsterdam, Netherlands)1 mentions
16. 2024An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities.Saudi journal of biological sciences1 mentions
17. 2024Hematopoietic cell transplantation and cell therapy activity landscape survey in the Kingdom of Saudi Arabia; a report from the Saudi Society of Blood and Marrow Transplantation (SSBMT).Bone marrow transplantation1 mentions
18. 2024Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy.Medical oncology (Northwood, London, England)1 mentions
19. 2024Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways.Cell biochemistry and function1 mentions
20. 2023Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.Blood advances1 mentions
21. 2023An overview on COVID-19 and vaccines: findings and learnings from the pandemic.European review for medical and pharmacological sciences1 mentions
22. 2023A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma.Journal of Taibah University Medical Sciences1 mentions
23. 2023Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats.International journal of molecular sciences1 mentions
24. 2023Therapeutic benefits of prophetic medicine remedies in treating hematological diseases (A review article).American journal of blood research1 mentions
25. 2022Exonic variants in multiple myeloma patients associated with relapsed/ refractory and response to bortezomib regimens.Saudi journal of biological sciences1 mentions
26. 2022The Clinical Features and Outcomes of Renal Amyloidosis in Tunisia.Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia1 mentions
27. 2021African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.Cancer1 mentions
28. 2021Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia.Annals of Saudi medicine1 mentions
29. 2020Multiple Myeloma in the Time of COVID-19.Acta haematologica1 mentions
30. 2020Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers.Saudi journal of medicine & medical sciences1 mentions
31. 2017Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase.Molecules (Basel, Switzerland)1 mentions
32. 2017Multiple Myeloma in a Patient With Familial Mediterranean Fever.Iranian journal of kidney diseases1 mentions
33. 2016Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.Toxicology mechanisms and methods1 mentions
34. 2016Fanconi syndrome due to light chain proximal tubulopathy in a patient with multiple myeloma.Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia1 mentions
35. 2015Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.Advances in hematology1 mentions
36. 2015Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).Hematology/oncology and stem cell therapy1 mentions
37. 2014Hypochondroplasia, Acanthosis Nigricans, and Insulin Resistance in a Child with FGFR3 Mutation: Is It Just an Association?Case reports in endocrinology1 mentions
38. 2011Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation1 mentions
39. 2010Listeria monocytogenes brain abscess in a patient with multiple myeloma.Journal of infection in developing countries1 mentions
40. 2008Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports.Cases journal1 mentions